Trillions – Détails, épisodes et analyse

For every stock that enters an index like the S&P 500 or Russell 1000, another must exit. One might assume these “deletions” are a sorrowful bunch whose demotion to the B-team means they’re no longer worthy of your portfolio. Yet Rob Arnott, founder of Research Affiliates and a longtime champion of “smart beta,” discovered that many of these rejects tend to perform better after being dropped from the indexes.

On this episode, Eric and Joel speak with Arnott about his new exchange-traded fund, $NIXT, which holds dozens of such stocks with equal-weighting. They discuss how the ETF—Arnott’s first launch—may complement your portfolio, what’s behind the performance, how the portfolio rebalances and why smart beta has endured.

See omnystudio.com/listener for privacy information.

The idea of using leverage to layer one investment return, say equities, on top of another, say a managed futures strategy, is something institutional investors have been doing for decades under the term “portable alpha.” Now a suite of young, fast-growing exchange-traded funds have come along—they’re called “return stacking” ETFs—and they’re offering such layering to the masses.

On this episode, Joel and Eric speak with Corey Hoffstein, chief executive and chief information officer of Newfound Research and one of the masterminds behind the Return Stacked ETF suite. They discuss how these ETFs work, where they fit in a portfolio and why this is a more responsible use of leverage than the kind that blew up the market in 2008. 

See omnystudio.com/listener for privacy information.

The issuer of an exchange-traded fund has one main goal, and that’s to get assets—but being recognized is nice, too. Just like the Oscars, the ETF industry has its own awards show, held by ETF.com every April in New York City. Categories include ETF of the Year, Issuer of the Year, Best New Fixed Income ETF and even a Lifetime Achievement Award. Now that the tenth annual ETF awards ceremony is in the history books, we can tell you that—just like the Academy Awards—there were some notable winners as well as a few surprises. 

Om this episode, Joel and Eric look through a number of winners with ETF.com's editor-in-chief Kristin Myers and finance reporter Lucy Brewster. 

See omnystudio.com/listener for privacy information.

In March, for the first time ever, a mutual fund went to sleep and woke up as an ETF. Two of them, in fact. And Guinness Atkinson, the issuer, couldn’t be happier about the experience — not that it didn’t take a lot of work to get across the finish line. Many more mutual funds will likely follow suit.

On this episode of Trillions, Eric and Joel — along with Claire Ballentine, the Bloomberg News reporter who covered the story — go deep with Guinness Atkinson’s Jim Atkinson and his lawyer, Alexandra Alberstadt about their new ETFs, the SmartETFs Dividend Builder ($DIVS) and SmartETFs Asia Pacific Dividend Builder ($ADIV). They discuss why they converted, what the process entailed, and how other issuers should approach the topic. Did we mention there will be many more of these?

See omnystudio.com/listener for privacy information.

Much like kids, ETFs can grow up so fast. And while you can expect the Vanguards and BlackRocks to keep hoovering up assets, there are many lesser-known products that have gained respectable followings. Sometimes it's quite shocking to see just how big they've gotten since the last time you checked on them. 

On this episode of Trillions, Eric and Joel are joined by Todd Rosenbluth, Director of Mutual & Exchange Traded Fund Research at CFA, Claire Ballentine, reporter for Bloomberg News and Athanasios Psarofagis, analyst for Bloomberg Intelligence. They discuss and debate eight ETFs that got surprisingly large, including: $XSOE, $IQLT, $IVOL, $SOXL, $BUZZ, $UFO, $TMFC and $BUG. 

See omnystudio.com/listener for privacy information.

Let's be honest, Real Estate Investment Trust (REIT) ETFs probably aren't going to make you blush or quicken your pulse. But they can be extremely practical in a portfolio. Typically known for their ability to generate income, this category of ETFs has seen rapid evolution of late with new entrants that focus on areas such as data centers. It's also made picking the right REIT ETF all the more confusing since there's now dozens of them.

On this episode of Trillions, Eric and Joel are joined by REIT trader David Auerbach of World Equity Group as well as Kevin Kelly, a managing partner of Benchmark Investments, the index provider for a few of the new REIT entrants. They discuss the basics of REITs, the pros and cons of category king $VNQ as well as the new generation of REIT ETFs such as $SRVR, $HOMZ, $NETL and, what else, $REIT.

See omnystudio.com/listener for privacy information.

A few decades ago, nobody really questioned vaccines. They were viewed as a standard part of staying healthy and safe. Today, the number of people questioning vaccines risks prolonging a pandemic that has already killed hundreds of thousands of Americans. How we got to this moment didn’t start with the rollout of vaccines or in March 2020, or even with the election of Donald Trump. Our confidence in vaccines, often isn't even about vaccines. It’s about trust. And that trust has been eroding for a long time. Doubt, a new series from Bloomberg’s Prognosis podcast, looks at the forces that have been breaking down that trust. We'll trace the rise of vaccine skepticism in America to show how we got here — and where we’re going. Doubt launches on March 23. Subscribe to Prognosis today on Apple Podcasts, Spotify or wherever you get your podcasts.

See omnystudio.com/listener for privacy information.

More than 150 years after the end of slavery in the U.S., the net worth of a typical white family is nearly six times greater than that of the average Black family. Season 3 of The Pay Check digs into into how we got to where we are today and what can be done to narrow the yawning racial wealth gap in the U.S.

Jackie Simmons and Rebecca Greenfield co-host the season, which kicks off with a personal story about land Jackie's family acquired some time after slavery that they're on the verge of losing. From there the series explores all the ways the wealth gaps manifests and the radical solutions, like affirmative action, quotas, and reparations, that can potentially lead to greater equality.

See omnystudio.com/listener for privacy information.

This month showed how much inflation concerns and an uptick in bond yields can mess with a portfolio. It showed the vulnerability of high flying investments such as bitcoin and ARK as well as how a 60/40 portfolio can have both the 60 and the 40 go down together. So yeah, inflation is a big deal. But is it real or just another head fake?

On this week's episode of Trillions we speak with Jim Bianco, president and founder of Bianco Research LLC, on why he's taking inflation more seriously this time and what a 60/40 investor can do. He also talks ARK ETFs and its haters, bitcoin's potential and why the retail day trader is here to stay even post-pandemic. 

See omnystudio.com/listener for privacy information.

Magic mushrooms, LSD and ketamine used to be associated with psychedelic trips and fun weekends. Now they’re increasingly viewed as serious medicine that can be used to treat ailments such as depression and PTSD. The small but fast-growing industry even has its first ETF — the Canadian-listed Horizons Psychedelic Stock ETF, or PSYK.

On this episode of Trillions, Eric and Joel speak with Steve Hawkins, the CEO of the firm behind the ETF, who was also behind the world’s first cannabis ETF. He talks the about sector outlook, underlying business fundamentals, the design of the ETF — and whether he plans to start micro-dosing LSD.

See omnystudio.com/listener for privacy information.